You have not yet added any article to your bookmarks!
Join 10k+ people to get notified about new posts, news and tips.
Do not worry we don't spam!
Post by : Badri Ariffin
Abu Dhabi has stepped into the future of medical care with the unveiling of the Abu Dhabi Biobank, an innovative initiative aimed at transforming disease detection, prevention, and treatment.
In collaboration with M42, the Department of Health – Abu Dhabi has developed this cutting-edge platform, marking a pivotal shift from conventional reactive healthcare to a proactive, data-oriented model that prioritizes early risk identification and individualized treatment.
The biobank, located in Masdar City, features a state-of-the-art net-zero facility designed to store over 100,000 cord blood samples and approximately five million biological specimens, establishing it as one of the most sophisticated health data collections in the area.
By merging biological samples with a spectrum of genomic, clinical, and lifestyle information on a population scale, this initiative empowers healthcare professionals to identify diseases at earlier stages, enhance diagnostic precision, and customize treatments according to individual patient profiles.
Key attendees at the launch event included prominent figures such as Mansoor Ibrahim Al Mansoori, Dr. Noura Al Ghaithi, and Dimitris Moulavasilis, together with representatives from renowned global healthcare organizations and academic institutions.
A notable component of the project includes the establishment of two significant features: a comprehensive pan-human biobank that links long-term health information, and a national eye bank designed to bolster local transplantation efforts and diminish dependence on imported tissues.
Experts affirm that this platform will not only enhance patient care through quicker disease identification and tailored interventions but will also advance global medical research efforts. Given its diverse population of over 200 nationalities, the biobank strengthens the applicability and efficacy of healthcare advancements on a worldwide scale.
Officials assert that the Abu Dhabi Biobank will serve as a “living platform,” continuously adapting by integrating real-world health information to bolster prevention initiatives, clinical decision-making, and pioneering research.
Dr. Noura Al Ghaithi noted that this initiative signifies a comprehensive shift in healthcare—from managing illness to preventing it—ultimately enhancing patient outcomes and quality of life.
Meanwhile, M42 CEO Dimitris Moulavasilis emphasized that the integration of biological data with AI and genomics will facilitate swifter insights, superior healthcare decisions, and enhanced outcomes across populations.
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
APEC members discuss responsible AI use, digital innovation and data governance as China and the US
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governa
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing
Singapore Warns Users About Privacy and Security Risks of AI Agents
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised acc
Chris Lynn Completes One-Month Ban After Positive Cocaine Test
Australian cricketer Chris Lynn completes a one-month ban after a positive cocaine test during the T
Djokovic Eyes Strong Season Finish as Health Improves Ahead of Paris Masters
Novak Djokovic reports improved health and performance as he targets a strong Paris Masters finish a